Public Company Healthcare

Phreesia

Wilmington, Delaware, United States

Phreesia provides technology that helps healthcare organizations understand their patients and equip them with the knowledge, skills, and confidence to succeed, with tools for patient registration, scheduling, payments, and clinical support.

Focus Areas
Patient activation & engagement, Patient intake & registration workflows, Patient outreach

Tracked deals

3

3 tracked deals across 2021-2023.

Recent pace

0

0 tracked deals announced in the last 12 months.

Deal mix

Buyout

3 buyout

Phreesia Acquisition Volume by Year

Last 2 years

Acquisition volume by year Annual acquisition counts for the last 2 years for Phreesia. 1 2021 2 2023

Supporting Data

Recent Transactions

  • Buyer
    Phreesia
    Target
    Access eForms
    Type
    Buyout

    Phreesia has acquired Access eForms, an electronic forms management and automation provider, to expand its offerings for acute-care hospitals and strengthen integrations with leading EHRs. Access eForms (founded over 20 years ago) processes more than 1.6 billion e-signatures annually and will complement Phreesia's patient intake, outreach and activation platform; Healthcare Growth Partners advised Access eForms on the transaction.

  • Buyer
    Phreesia
    Target
    MediFind (Comsort, Inc. d/b/a MediFind)
    Location
    United States
    Type
    Buyout

    Phreesia has acquired Comsort, Inc. d/b/a MediFind to expand its patient-centered offerings and consumer-facing capabilities. MediFind uses machine learning and proprietary analytics to help patients—particularly those with serious, chronic, and rare conditions—find leading doctors, clinical trials and treatments; MediFind CEO Patrick Howie has joined Phreesia as Vice President of Product Management.

  • Buyer
    Phreesia, Inc.
    Target
    Insignia Health, LLC
    Seller
    Chris Delaney, Craig Swanson, University of Oregon, Other holders of membership interest
    Type
    Buyout

    Phreesia, a public healthcare SaaS company based in Raleigh, North Carolina, has acquired Insignia Health, LLC, the exclusive license holder of the Patient Activation Measure (PAM). The deal brings Insignia's patient activation assessment, education and coaching capabilities into Phreesia's patient engagement platform to expand capabilities and scale PAM across Phreesia's provider and payer customers.

Related Acquisition Pages

Selling a company? Get in front of buyers like Phreesia

Turn tracked acquisition activity into an outreach-ready buyer list.